Selective estrogen receptor modulators regulate stromal proliferation in human benign prostatic hyperplasia by multiple beneficial mechanisms-action of two new agents

Author： Kumar Rajeev  

Publisher： Springer Publishing Company

ISSN： 0167-6997

Source： Investigational New Drugs, Vol.30, Iss.2, 2012-04, pp. : 582-593

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Review of Animal and Human Studies for Management of Benign Prostatic Hyperplasia with Natural Products: Perspective of New Pharmacological Agents

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 11, Iss. 3, 2012-06 ,pp. : 207-221

Bentham Science Publishers

Access to resources Recommend Favorite

Selective Estrogen Receptor Modulators (SERMs): Effects on Multiple Organ Systems

By  

Current Medicinal Chemistry, Vol. 7, Iss. 5, 2000-05 ,pp. : 577-584

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetics of Selective Estrogen Receptor Modulators

By Morello K.C.   Wurz G.T.   DeGregorio M.W.  

Clinical Pharmacokinetics, Vol. 42, Iss. 4, 2003-01 ,pp. : 361-372

Adis International

Access to resources Recommend Favorite

Phytotherapeutic Agents for Benign Prostatic Hyperplasia: An Overview

By  

Mini Reviews in Medicinal Chemistry, Vol. 17, Iss. 14, 2017-08 ,pp. : 1346-1363

Bentham Science Publishers

Access to resources Recommend Favorite

Intraprostatic botulinum toxin A appears to be beneficial for patients with benign prostatic hyperplasia

By  

Inpharma, Vol. 1, Iss. 1565, 2006-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite